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Sunnnary 
We isolated major histocompatibility complex (MHC)-specific viral peptides from cells infected 
with influenza virus in the continuous presence of the drug brefeldin A, which blocks exocytosis 
of newly synthesized MHC class I molecules. MHC-specific peptides were also isolated from 
cells expressing mouse K a class I MHC molecules whose cytoplasmic domain was substituted 
by that of the adenovirus E3/19K glycoprotein. This molecule was retained in an intracellular 
pre-Golgi complex compartment as demonstrated  by immunocytochemical  and biochemical means. 
Since we show that intraceUular association of antigenic peptides with such retained class I molecules 
is necessary for their isolation from cellular extracts,  this provides direct evidence that naturally 
processed  peptides associate with class I  MHC  molecules in  an  early  intracellular exocytic 
compartment. 
C 
D8  T lymphocytes (Tcns+) play an important role in 
eradicating intraceUular parasites (viruses and unicellular 
organisms) and neoplasms (1). TcDs+ recognize dass I mol- 
ecules of the MHC bearing peptides of 8-10 residues derived 
from antigenic proteins (2, 3). Class I molecules consist of 
a 43-kD polymorphic transmembrane oe chain noncovalently 
associated  with  12-kD 32-microglobulin. Chain assembly 
occurs within minutes after biosynthesis, probably within 
the endoplasmic reticulum (ER).I Class I molecules are then 
transported to the cell surface via the Golgi complex and 
post-Golgi complex vesicles. 
A critical issue in understanding dass I-mediated antigen 
presentation is the identity of the compartment in which class 
I molecules associate with antigenic peptides. Through the 
use of mutant cells it has been established that at least two 
gene products (termed TAP1 and TAP2 [transporter associated 
with antigen processing]) encoded by the MHC are needed 
for efficient presentation of biosynthesized antigens. These 
proteins are thought to form a transporter capable of con- 
veying antigenic peptides from the cytosol to an intracellular 
exocytic compartment (4-7).  In TAP-deficient  cells, class I 
molecules are often retained in the ER (8-11). This conclu- 
sion is consistent with findings that presentation of biosyn- 
thesized antigens is blocked by agents that interfere with the 
egress of class I molecules from early exocytic compartments. 
One such agent is the fungal metabolite brefeldin A (BFA). 
1Abbreviations used in  this paper: BFA, brefeldin A; ER,  endoplasmic 
reticulum; HA, hemagglutinin; NP, nucleoprotein; W, vaccinia virus. 
Upon addition of BFA to cells, the Golgi complex rapidly 
disassembles and is transported, at least in part, in a retro- 
grade manner to the ER (12-16).  Newly synthesized mem- 
brane or secretory proteins are retained in an early secretory 
compartment in BFA-treated  cells. BFA completely blocks 
the ability of virus-infected cells to present antigens to virus- 
specific TCDS+ (17, 18). Another agent that blocks antigen 
presentation is the adenovirus E3/19K membrane glycopro- 
tein, which binds class I molecules (without blocking pep- 
tide association)  and retains them in the ER by virtue of a 
sequence in its COOH-terminal cytosolic tail (19-27).  The 
inhibitory effects of BFA and E3/19K on antigen presenta- 
tion have two general explanations: either these agents pre- 
vent class I molecules from reaching a distal secretory com- 
partment where antigen association occurs, or they prevent 
the egress of class I molecules that are bound to antigenic 
peptides. 
To distinguish between these possibilities, we determined 
whether naturally processed viral peptides could associate with 
class I molecules retained intracellularly through the action 
of BFA or due to the replacement of the cytosolic domain 
with that ofE3/19K. Peptide association was measured using 
the method described by Ik6tzschke et al. (28, 29), in which 
acid-soluble peptides of <5 kD are separated via reverse-phase 
HPLC. We demonstrate that the recovery of peptides by this 
method requires  that the peptides bind to the appropriate 
class I molecule in an intracellular compartment, and is, there- 
fore, a valid method of examining whether peptides can as- 
sociate with intracellular forms of class I molecules. 
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Cells and Virus.  RMA cells (H-2  b) (generously  provided by Dr. 
K. Karre, Karolinska Institute, Stockholm, Sweden) were main- 
tained in RPMI 1640 supplemented with 7.5% (vol/vol) FCS in 
an air/CO2 (94/6%)  atmosphere. L929 cells (H-2  k) were main- 
rained in DMEM supplemented with 7.5% (vol/vol) FCS in an 
air/COs  (91/9%)  atmosphere. The influenza virus A/PR/8/34 
(PR8) was propagated in the allantoic cavities of 10-d-old chicken 
eggs and stored as infectious aLlantoic  fluids. Recombinant vaccinia 
viruses (W) were propagated as described (30, 31). The production 
and characterization  of W  expressing  influenza  virus nucleoprotein 
(NP), hemagglutinin (HA), and H-2 K  a have been described (32, 
33). The production and characterization  of VV expressing an ER- 
retained form of K  d will be described in detail elsewhere (BaUlk 
et al., manuscript in preparation), 
Mice and Generation of CTL.  6-8-wk-old C57BL/6 (H-2 b) or 
BALB/c (H-2  a) mice were obtained from The Jackson Laboratory 
(Bar Harbor, ME). Mice were immunized by intravenous injection 
with 5  x  10  s PFU of VV recombinants. TCD8+ were generated 
from splenocytes  derived  from animals  immunized with W  recom- 
binants 2-6 wk previously by 7-d in vitro stimulation with PRB- 
infected autologous splenocytes  as described  (30, 31). In this manner 
HA-specific Tens+ were generated from mice immunized with 
VV-HA, and NP-specific Tcos+ were generated from mice im- 
munized with VV-NP. Clone 17 is an NP-specific, Db-restricted 
clone produced as described (34). 
PeFa'de  Isolation and Cytotoxicity  Assays.  To isolate  PR8 peptides, 
109 RMA ceUs were infected for 8 h at 37~  with 25,000 HALT 
of PR8. To isolate peptides from VV-infected  cells, 5  x  10  s cells 
were infected for 5 h at 37~  at a multiplicity of infection of 5 
PFU for each W  recombinant. BFA was added to cells at 5 #g/ml 
10 min after the addition of virus and was maintained throughout 
the infection. Peptides were isolated essentially as described (35). 
Briefly, cells were Dounce homogenized in 20 ml 0.1% TFA at 
room temperature, sonicated  in the cold, rotated for 30 rain at 4~ 
and centrifuged at 10,000 rpm in an SW28 rotor (Beckman Instrs. 
Inc., Palo Alto, CA) for 15 min. Superuatants were dried overnight 
in a Speedvac (Savant Instrs., Inc., Farmingdale, NY), and pellets 
dissolved  in 0.1% TFA were chromatographed  using a G-25 cohmn 
(bed volume, 100 ml; eluent,  0.1% TFA/water;  flow rate, 1.0 
ml/min). Material of<5 kD was dried, suspended in 200 ~10.1% 
TFA, and subjected to reverse-phase HPLC. Samples were chro- 
matographed using a Delta Pak C-18, 300-A column (3.9 mm  x 
30 cm with 15-~m spherical  particles; Waters Associates, Milford, 
MA). The following  gradient was used: eluent 1, 0.1% TFA/water; 
eluent 2, 0.1% TPA/acetonitrile (1 ml/min, 1-ml fractions); gra- 
dient: 0 min, 95% 1 and 5% 2; 30 min, 50% 1 and 50% 2; 45 
rain, 0% 1 and 100% 2; 50-60 min, 95% 1 and 5% 2. Fractions 
were dried overnight and suspended in 200 ~1 PBS. To test for the 
presence of antigenic peptides, 10 #1 was added to 104 SlCr-labeled 
cells in 100 #1 Iscove's modified DMEM supplemented with 7.5% 
FCS (IDMEM), and TcDs+ were added in 100 pl IDMEM. After 
a 4-h incubation at 37~  100 pl of supernatant was harvested and 
the amount of released SlCr determined by gamma counting. Per- 
cent specific release was calculated as: 100x [(experimental cpm 
-  spontaneous cpm)/(total  cpm  -  spontaneous cpm)]. 
Biochemical Methods.  2 x  107 L929 cells infected for 1 h with 
VV were incubated for 30 min in 2 ml methionine-free DMEM 
for 30 min at 37~  After adding 200 pCi [3SS]methionine, cells 
were incubated for an additional 5 rain at 37~  After washing, 
cells were incubated for 0-3 h at 37~  before incubation at 0~ 
Cells were then incubated for 20 min at 0~  with 0.14 M NaC1, 
1 mM EDTA, 1% Triton X-100, 1 mM PMSF, 10 mM Tris HC1, 
pH 7.4, and the nuclei pelletted by centrifugation at 15,000 g. Su- 
pernatants were incubated  with protein A-Sepharose preloaded  with 
the anti-K  d mAb, SF 1.1.1 (HB-159; American Type Culture Col- 
lection, Rockville, MD). After extensive washing, class I mole- 
cules were eluted from beads by boiling in 0.1 M sodium acetate, 
3 mM EDTA, 0.25% SDS, pH 6. Samples were split in half, in- 
cubated overnight at 37~  with or without 2 mU endo-B-N- 
acetylglucoseaminidase  H (Endo H), and analyzed by SDS-PAGE. 
After fixing and staining with Coomassie  blue, gels were incubated 
with Amplify (Amersham Corp., Arlington Heights, IL), dried 
under vacuum, and exposed to preflashed  film. Fluorographs were 
developed using an automated film processor. 
Immunocytochemical  Methods.  VV-infected  cells were fixed  by in- 
cubating with 1% (wt/vol) paraformaldehyde  in PBS for 20 min 
and permeabilized  by including saponin (0.1% [wt/vol]) in all sub- 
sequent steps. Cells were incubated for 30 rain at 0~  with PBS 
containing 2% BSA and 20% hybridoma tissue culture superna- 
tant, washed, and incubated with FITC-conjugated rabbit anti- 
mouse IgG for an additional 30 min. Washed cells were analyzed 
using an Epics Profile  flow cytometer. To localize  intracellular class 
I molecules, L929 cells grown on acid-cleaned  coverslips infected 
for 5 h with W  were fixed with 3% paraformaldebyde  and per- 
meabilized as above. Cells were incubated first with a rabbit an- 
tisera specific for a protein localized to the medial-Golgi complex 
(36),  and  after  washing, with  Texas red-conjugated  donkey 
anti-rabbit IgG and FITC-conjugated SF 1.1.1 (Pharmingen, San 
Diego, CA). Coverslips were mounted with Mowiol containing 
5% (wt/vol) diazobicyclo-octane,  and observed using a laser scan- 
ning confocal microscope (LCSM; MRC600; Bio-Rad Laborato- 
ties, Richmond, CA). Red and green fluorescent  images  were simul- 
taneously acquired  using the fast photon counting mode. Controls 
established that red and green fluorescence  did not bleed into the 
inappropriate channel. Images were further manipulated using a 
Macintosh computer and Adobe Photoshop (Adobe Systems In- 
corp., Mountain View, CA) to alter eight-bit  bhck-and-white  images 
into eight-bit red and green images that were then merged to dem- 
onstrate the relationship  between staining  patterns. Prints were pro- 
duced by a Kodak XL7700 color printer. 
Results 
Recovery of  Antigenic Peptides  frora BFA-treated Cells.  RMA 
cells (a lymphoid cell line derived from H-2  b mice) were in- 
fected for 8 h with PR8, and acid-soluble  peptides derived 
from the cells were fractionated by HPLC and tested for their 
ability to sensitize SlCr-labeled R/VIA cells for lysis by poly- 
donal Db-restricted,  influenza virus NP-specific  TcDs +, or 
clone 17, a Db-restricted,  NP-spedfic TcDs+ clone (Fig.  1). 
Lysis was not observed  in the absence of Tcx)s+, which in- 
dicates that the fractions do not contain material capable of 
inducing SlCr release.  Fractions  14  and 15  were found to 
sensitize cells for lysis by NP-specific  TcDs +. Occasionally, 
peptide was recovered from fraction 10, but in these instances 
>95% of the activity was present in fractions 14 and 15. This 
correlates  with the recovery of virtually all of the antigenic 
activity in fractions 14 and 15 after identical HPLC analysis 
of a synthetic peptide corresponding to NP 366-374 added 
to extracts of uninfected RMA cells (not shown). This pep- 
tide is known to represent  the naturally processed  peptide 
recognized by Db-restricted,  NP-specific  TCDS+ (28,  35). 
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HPLC  FRACTION 
Figure  1.  Effect  of BFA on the recovery of influenza virus NP peptides from R.MA cells. HPLC fractions from uninfected RMA cells (~), or 
RMA cells infected with PK8 in the absence (O) or presence (N) of BFA, were tested for their ability to sensitize RMA cells (/eft and middle),  or 
P815 cells (right)  to lysis  by various Tcos .. Effector cells are listed above the respective panel. For positive controls, RMA cells were incubated with 
the NP 366-374 synthetic peptide, and P815 cells were incubated  with the NP 147-155 synthetic peptide (V). For negative contrds, cells were incubated 
with saline; this resulted in <4% lysis. 
Fractions derived from uninfected cells failed to sensitize R/vIA 
cells for lysis by NP-specific TCDS  +, demonstrating the re- 
quirement for viral gene expression in peptide formation. Frac- 
tions from PIL8-infected cells did not sensitize P815  cells 
(H-2 a)  for  lysis  by  H-2d-restricted,  virus-specific  TcDs+, 
providing one measure of the MHC dependence of peptide 
existence in RMA cells (not shown). Another measure of 
the MHC dependence of peptide isolation is the failure of 
NP-specific TcDs+ from BALB/c mice (H-2 a) to recognize 
cells sensitized with HPLC fractions from PR8-infected RMA 
cells, despite their ability to lyse cells sensitized with a syn- 
thetic peptide consisting of residues 147-155, known to rep- 
resent the naturally processed determinant from NP recog- 
nized in association with K a (Fig.  1). 
In the same experiment, cells were infected for 8 h in the 
continuous presence of BFA. To ensure that BFA was active 
in blocking antigen presentation, small aliquots of cells were 
labeled with  StCr  and  tested for recognition by clone  17 
cells. This confirmed that BFA-treated cells failed to display 
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su~cient class I-peptide complexes on their surfaces to en- 
able TcDs+ recognition (not shown). Despite the failure of 
BFA-treated cells to present NP to TcDs+, it was possible 
to recover a considerable amount of NP peptide from the 
cells. Peptides were present only in fractions 14 and 15 (Fig. 
1). As with non-BFA-treated cells, antigenic activity recov- 
ered from cells was MHC restricted, since none of fractions 
sensitized  P815  cells  for  recognition  by  H-2d-restricted 
TcDs+  (not shown). 
To compare the amounts of peptides recovered from BFA- 
treated and untreated RMA cells, twofold dilutions of peptide- 
containing fractions were tested for their ability to sensitize 
cells for lysis by clone 17 cells. In two completely indepen- 
dent experiments, the amount of peptide recovered from BFA- 
treated cells was 20 and 50% of that obtained from untreated 
cells (not shown). In a parallel experiment we determined 
that BFA has some inhibitory effect on viral gene expression 
in RMA cells. After 8.5 h of infection, BFA-treated cells ex- 
pressed 25% the amount of NP as untreated cells, as deter- mined by an ELISA of cell extracts using a NP-specific mAb 
(not shown). Thus, taking into account the decreased pool 
of NP, we conclude first, that BFA does not effect the gener- 
ation of antigenic peptides or their association with class I 
molecules in influenza virus-infected RMA cdls, and second, 
that intracellular peptide-class I complexes formed under these 
conditions are relatively stable. 
To generalize our findings, we performed a similar experi- 
ment using P815  (a mastocytoma derived from H-2  a mice) 
infected with PR8 in the presence or absence of BFA (Fig. 
2). Cell-derived acid-soluble peptides fractionated by HPLC 
were tested for their ability to sensitize P815 cells for lysis 
by  H-2  Ka-restricted  TcDs+  specific  for  HA  or  NP.  As 
above,  NP-specific effectors recognized peptides present in 
a single peak. By contrast, HA-specific effectors recognized 
peptides in two distinct peaks,  which presumably contain 
two distinct peptides recognized by the polyclonal HA-specific 
TcDs + populations. Infection of cells in the presence of BFA 
had little effect on the isolation of peptides, as antigenic pep- 
tides were recovered in the same fractions at roughly the same 
amounts. As above, the effectiveness of BFA at blocking an- 
tigen presentation was confirmed by testing an aliquot of cells 
used to isolate peptides in a standard SlCr release assay using 
influenza  virus-specific  TCD8+ (not  shown).  The  MHC- 
dependent nature of peptide recovery was confirmed by the 
failure of the extracts to sensitize RMA ceils for lysis by D b- 
restricted, NP-specific Tops + (not shown). 
Recovery of  Antigenic Peptides  from Class I Molecules with an 
ER Retention Sequence.  We further studied peptide associa- 
tion using cells infected with a VV expressing a modified 
form of K d, whose cytosolic domain was replaced with that 
of E3/19K (termed EC15 Kd). Transfer of the cytosolic do- 
main of E3/19K to the COOH terminus of other membrane 
proteins has been shown to result in their retention in the 
ER (37).  We initially compared the intracellular transport 
of EC15 K a to wild-type K a by immunoprecipitation of K d 
from detergent extracts of cells radiolabeled with  [35S]me- 
thionine for 5 min and chased for up to 3 h. Immunoprecipi- 
Figure  3.  Intracellular transport of  class I molecules. L929 cells infected 
with Kd-VV or EC15 Ka-W were radiolabeled for 5 rain with [3sS]me- 
thionine and chased for 0, 1, 2, and 3 h at 37~  Detergent extracts were 
immunoprecipitated  with a Kd-specific  mAb. Half of the immunoprecipi- 
tates were digested with Endo H  (+). Displayed is a fluorograph  of im- 
munoprecipitates analyzed by SDS-PAGE. We are uncertain as to why both 
wild-type K  d and  EC15 K  a run as doublets.  It cannot be attributed  to 
differences in N-linked glycosylation,  since molecules deglycosylated by 
Endo H display a similar pattern.  It is also unlikely to represent trimming 
at the COOH terminus  since this would be expected to allow EC15 K  d 
to leave the ER, or at the NH2 terminus,  since this would probably in- 
terfere with the folding  necessary for interaction  with the mAb used. 
tated  molecules were treated with  Endo  H  to  determine 
whether their N-linked oligosaccharides were exposed to the 
modifying enzymes of the medial-Golgi complex, whose ac- 
tions result in resistance of oligosaccharides to Endo H diges- 
tion. This revealed that while most wild-type K d molecules 
became resistant to Endo H  digestion 3 h after synthesis, all 
EC15  K d detected throughout  the chase period  remained 
sensitive to Endo H  digestion (Fig. 3). We further localized 
EC15  K a in  fixed and  permeabilized  cells  by double  im- 
munofluorescence. While K a clearly could be observed on 
the cell surface (not shown) or in the Golgi complex (Fig. 
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Figure  2.  Effect of BFA on the 
recocery of influenza virus NP and 
HA peptides from P815 cells. Acid- 
soluble antigenic peptides from P815 
!  cells infected with PR8 in the ab- 
sence (F-l) or presence (O) of BFA 
were recov~xed  and HPLC fraction 
ated as described  in Materials  and 
Methods.  BALB/c TCDS  § were de- 
rived from mice with a VV recom- 
binant expressing  HA or NP and 
stimulated  in  vitro  with  PR8- 
infected  autologous  cells. TcDs. 
generated in this manner have been 
shown  to  be  specific for  the  in- 
fluenza virus  gene  product  expressed 
by the VV recombinant  used for 
priming (24). Figure  4.  Immunofluorescent localization of K  d molecules. L929 cells infected with EC15 K  d VV (top) or wild-type Kd-W (bottom) were fixed 
and permeab'tlized  and stained for K  a (left)  or the resident medial-Golgi  complex protein MG160 (right). The relationship  between the patterns is shown 
in the middle by coloring K  d fluorescence  green and MG160 fluorescence  red and merging the images. This demonstrates that the distribution of EC15 
K  d, which is typical of the ER, is not related to the Golgi complex. By contrast, in addition to its ER distribution, wild-type Kd colocalizes  with 
the Golgi complex, as clearly  visualized  in the intensely  yellow areas of  the merged image. Images were acquired  with a scanning laser  cofocal  microscope. 
4,  bottom),  in addition to the ER,  EC15 was only detected 
in the ER (Fig. 4, top).  The failure of EC15 K a to reach the 
plasma membrane in appreciable amounts was confirmed by 
cytofluorography (Table 2, nonpermeabilized).  These findings 
indicate that EC15 K d is retained in an early secretory com- 
partment,  probably  the ER. 
Table  1.  Presentation of NP by L929  Cells Infected 
with  Recombinant  VVs 
Percent specific SlCr 
release 
L929 Cells  40:1  13:1 
Uninfected  2  1 
NP-VV  0  0 
Kd-VV  4  2 
Ka-VV  +  NP-VV  69  53 
EC15  Ka-VV  1  0 
EC15  Kd-VV + NP-VV  4  3 
Uninfected calls or cells infected for 5 h were tested in a 5-h slCr release 
assay at the E/T ratios indicated. Kd-restricted TCD8+ specific  for NP 
were generated as described (49). 
The intracellular retention of EC15 K d was further dem- 
onstrated functionally. L929 cells coinfected with EC15 K d- 
VV  and  a VV  recombinant  expressing NP  (NP-VV)  were 
not  recognized  by  polyclonal  Kd-restricted,  NP-specific 
TcDs+  as determined by a standard SlCr release assay,  while 
cells coinfected with NP-W  and a W  recombinant expressing 
unmodified K a (Kd-VV)  were efficiently lysed by the same 
TcD8+  population  (Table 2).  Cytofluorographic analysis of 
permeabilized cells indicated that  this cannot be attributed 
to lack of expression of NP or K d (Table 1).  Most  impor- 
tantly,  equivalent amounts  of peptide were recovered from 
cells expressing K d and EC15 K d (Fig. 5). Antigenic peptides 
were not recovered from cells infected with only EC15 K d- 
VV,  establishing  that  the peptides  were derived from  NP. 
The class I-specific nature of peptide isolation was demon- 
strated by our failure to isolate antigenic peptides from cells 
infected with only NP-VV. In an additional experiment, NP- 
VV-infected  L929  cells  were  mixed  with  EC15  K d  VV- 
infected L929 cells, or with P815 cells infected with HA-VV, 
and  the mixtures  were processed for peptide  isolation.  As 
a positive control, peptides  were also extracted from L929 
cells  coinfected with  EC15  Kd-VV  and  NP-VV.  Peptides 
were only recovered from cells simultaneously expressing NP 
and K a (Fig. 6). Taken together, these findings extend prior 
findings by first, providing a direct demonstration that class 
I  molecules are the only MHC  gene product  necessary for 
peptide isolation, and second, establishing  that peptides re- 
1637  Lapham  et al. 50- 
g 
40: 
o  30- 





....  I  ....  I  ....  I  ....  I  .... 
10  15  20  25 
-40 
-35  50- 
-30  40: 
-25  30- 
-20 
15  20- 
10  10, 
5 




i40  [] 
35  ~  A 
:-3o  ! 
i  vo  25 
￿9  20  "~  " 
.15 
￿9  10  o~ 
.5 
~0 
10  15  20  25  30 
EC15 Kd-Vac 
NP-Vac 
EC15 Kd Vac+NP-Vac 
Kd Vac+NP-Vac 
HPLC FRACTION NUMBER 
Figure 5.  Isolation of Kd-associated  NP peptides from L929 cells infected with W  expressing normal or EIL-retained K  d molecules. Antigenic pep- 
tides were recovered from L929 cells infected with each of the following vaccinia viruses: NP-W (A); EC15 Ka-W(cytosolic tail rephced by the 15 
COOH-terminal residues from the adenovirus E3/19K glycoprotein) ([]); EC15 KJ-W  +  NP-VV (O); or K'LW  +  NP-VV (0).  Peptides were 
used to sensitize P815 cells for lysis by NP-specific TcDs+ derived from BALB/c mice. 
covered from cells are derived from peptide-class I complexes 
formed intracellularly, and not in lysis buffer during or after 
cell disruption. 
Discussion 
Del Valet al. (38) recently reported that cells infected with 
murine cytomegalovirus contained antigenic peptides derived 
from a viral protein despite the fact that the cells failed to 
display sufficient peptide-class I complexes on the cell sur- 
face to enable lysis by TcDs + specific for the peptide. They 
also noted that cytomegalovirus infection hindered the trans- 
port of newly synthesized class I molecules, as determined 
by the sensitivity of N-linked oligosaccharides to digestion 
with Endo H. These findings indicate that under these con- 
ditions, antigen association occurs before the passage of class 
I molecules through the medial-Golgi complex, which is the 
presumed location of Golgi mannosidase II, whose action 
generally renders N-linked oligosaccharides resistant to diges- 
tion with Endo H. 
In the present study we confirm by two different strate- 
gies the general finding that peptides can associate with class 
I molecules in an intracellular location, and extend this finding 
to include at least three more viral determinants (four if HA 
has two distinct determinants recognized in association with 
Kd).  First, we demonstrated that antigenic peptides can be 
recovered from BFA-treated cells. Since BFA renders the cells 
insensitive to lysis  by TcDs+  specific for the peptides, we 
conclude that the peptides are derived from intracellular class 
I molecules. This finding directly demonstrates that the myriad 
effects of BFA on intracellular membranes do not grossly affect 
either the formation of antigenic peptides, or their transport 
Table  2.  Cytofluorographic  Analysis of VV-infected L929 Cells Used  for Peptide Isolation 
Permeabilized 
Anti-K  a  Anti-NP 
Nonpermeabilized 
Anti-K  a 
Percent positive  MCF  Percent positive  MCF  Percent positive  MCF 
NP-VV  3.5  21.5  94.2  60.6  3.5  6.6 
EC15KO-VV  85.7  43.0  3.92  16.5  2.4  6.2 
EC15Ka-VV  +  NP-VV  69.1  29.6  90.1  55.3  3.7  6.4 
Kd-VV  +  NP-VV  82.5  30.1  93.5  62.0  53.6  6.7 
L929 cells infected for 5 h with the indicated recombinant VV were indirectly stained with mAbs specific for K  a or NP and analyzed using a flow 
cytometer.  To detect intraceUular antigens, cells were aldehyde fixed and permeabilized using saponin. To detect antigens on the cell surface, viable 
cells were used. Data are expressed as percent positive relative to cells stained with only the second fluorescent antibody, and the mean channel fluores- 
cence (MCF)  of positive cells. 
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Figure 6.  Isolation  of NP peptides from cells expressing K  d requires 
the simultaneous  expression of K  d and NP in the same cell. L929 cells 
were  infected  with NP-W and were  mixed  with L929 cells infected  with 
EC15 Ka-W (O) or P815 (H2  a) cells infected  with CrI9W (A). In ad- 
dition, L929 cells were simultaneously  infected  with NP-VV and EC15 
Ka-W (Q). Antigenic  peptides  were  isolated, and peptides  in I-IPLC frac- 
tions, saline  (UI), or NP 147-155 synthetic  peptide (~) were  used  to sen- 
sitize P815 cells for lysis  by NP-speciiic  TCDS+ derived  from BALB/c  mice. 
from the cytosol to class I molecules. Due to the disruption 
of both the early and later proteins of the secretory pathway 
by BFA, it is not possible  to infer the site of association of 
peptide with class I molecules, other than to conclude that 
association occurs before the delivery of class I molecules to 
the most distal regions of the trans-Golgi complex (known 
as the trans-Golgi network), which has been reported to be 
resistant to the effects of BFA on exocytosis (39,  40). 
To more precisely determine the site of peptide association 
with class I molecules, we genetically engineered a K a mol- 
ecule containing the ER retention sequence of the E3/19K 
glycoprotein. This molecule does not acquire Endo H resis- 
tance, consistent with retention in an early secretory com- 
partment. Immunofluorescence localization further suggests 
that the molecule is genuinely retained in the ER.. Thus our 
finding that cells  expressing EC15  K a do not present NP 
peptides to TcDs +, yet contain similar amounts of antigenic 
peptides as cells expressing wild-type K a, indicates that class 
I molecules can associate with peptides in the ER itself, or 
in the c/s-Golgi network, which might play a role in main- 
taining the ER localization of EC15  K a (11). 
The localization of peptide association to the early secre- 
tory pathway is consistent with the immunocytochemical  lo- 
calization of TAP1 to the ER and c/s-most elements of the 
Golgi complex (41). Moreover, it indicates that peptides de- 
livered to the ER by the addition of signal sequences (42, 
43),  or indeed signal sequences themselves (44,  45), likely 
associate with class I molecules in the EK, and not in a more 
distal portion of the secretory pathway. 
Based on coelution in HPLC of HA and NP antigenic pep- 
tides derived from BFA-treated and untreated cells, and NP 
peptides derived from K d- and EC15 Kd-expressing cells, it 
is possible that peptides isolated from retained class I mole- 
cules are identical to those displayed on the cell surface for 
TCDS + recognition. This would suggest either that intracel- 
lular trimming of peptides associated with class I molecules 
is not a major source of the 8-10mers that bind to class I 
molecules with highest affinity, or that trimming occurs very 
rapidly. On the other hand, under the conditions used for 
HPLC, longer synthetic peptides have been found to coelute 
with naturally isolated peptides. We found, for example, that 
synthetic peptides consisting of residues 366-377,  367-376, 
or 367-377 coeluted with 366-374 under these conditions. 
We observed in several experiments that NP peptides derived 
from BFA-treated RMA cells were more heavily represented 
in fraction 15 than 14, while peptides from nontreated cells 
had the opposite distribution, suggesting that these peptides 
are not identical. It should be possible to determine whether 
longer peptides are present on intracellular class I molecules 
via chemical analysis,  as recently described (46),  and thus 
directly assess the possibility that peptides are trimmed after 
binding to class I molecules. 
The association of antigenic peptides with class I mole- 
cules in the EK is, in some respects, a curious evolutionary 
choice. First,  the EK is voluminous (occupying ~10%  of 
the volume of some cells), which would not favor the binding 
of low amounts of peptides if they were simply delivered to 
the EK lumen by the transport  process.  Second, peptide 
binding molecular chaperones (such as BiP/GRP 71) are present 
in the ER at very high concentrations (47,  48), and might 
be expected to compete for peptide binding with class I mol- 
ecules. The ability of class I molecules to efficiently bind an- 
tigenic peptides in the face of these difficulties has several in- 
teresting possible explanations.  (a) Antigen association occurs 
in subdomains in which class I and TAP molecules are con- 
centrated, perhaps by being physically linked to one another 
(such links would have to be tenuous since coprecipitation 
has not been reported, even in crosslinking studies [49]); (b) 
antigenic peptides are selected for their low affinity for mo- 
lecular chaperones; and (c) peptide transfer to class I mole- 
cules is facilitated by an unidentified gene product. 
Finally, consider the possibility that the choice of the EK 
for antigen association is a remnant of the evolutionary origins 
of antigen processing. The first antigens presented by primor- 
dial class I molecules might have been signal peptides, or pep- 
tides produced by the proteolytic processes believed to occur 
in the EK. Later, TAP genes might have evolved to broaden 
the types of peptides presented by class I molecules by al- 
lowing class I molecules access to peptides present in the 
cytosol. It will be of interest to determine if nonmammalian 
MHCs encode TAP homologues. If organisms can be identified 
that lack TAP genes, it  might be possible to observe the 
primordial antigen processing system at work. 
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